In an interview with PharmaShots, Emmanuel Dulac, Pharm.D., Ph.D., President and CEO of Zealand Pharma shares insight on the US FDA’s approval of Zegalogue and its availability in both an auto-injector […]readmore
Tags : Hypoglycemia
Shots: The new Glucagon Emergency Kit allows clinicians flexibility and choice to treat patients experiencing severe hypoglycemia and is convenient & easy to use with the availability of the co-pay […]readmore
Shots: The FDA’s approval follows multiple studies with various age group evaluating baqsimi (glucagon, 3mg) nasal powder vs glucagon injection formulation in patients with diabetes aged 4yrs and older Collective […]readmore
Shots: The SMILE study involves assessing of MiniMed 640G system with SmartGuard technology vs insulin pump therapy without continuous glucose monitoring (CGM) in 153 adults with T1D, prone to severe […]readmore